Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News InnoCan Pharma Corporation C.INNO

Alternate Symbol(s):  INNPF

Healthcare Drug Manufacturers - Specialty & Generic
InnoCan Pharma Corporation operates as a pharmaceutical technology company in United States, Canada, Europe, and internationally. The company operates through two segments: Pharmaceuticals and Consumer Wellness. The company's Pharmaceutical segment engages in the development of drug delivery technologies for both human and animal health applications, based on advanced cannabinoids science. It... see more

Recent & Breaking News (CSE:INNO)

Innocan Pharma Announces First Half Of 2025 Financial Results

Canada NewsWire August 27, 2025

Innocan's Findings to be Showcased in Scientific Poster Reception at PAINWeek 2025 Conference in Las Vegas, Nevada

Canada NewsWire August 22, 2025

Innocan Pharma Announces Public Filing of Registration Statement for Proposed U.S. Public Offering

Canada NewsWire July 23, 2025

Innocan Pharma Announces Promising Results of LPT-CBD Administered to Gottingen Minipigs, providing a good translational model and Provides Corporate Update

Canada NewsWire July 3, 2025

Innocan Pharma Announces Presentation of Narrative Review on Long-Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference

Canada NewsWire June 20, 2025

Innocan Pharma Highlights Breakthrough Narrative Review on Liposomal Synthetic CBD for Chronic Pain: A Novel Non-Opioid Analgesic Approach

Canada NewsWire June 13, 2025

Innocan Pharma Announces First Quarter 2025 Financial Results with Continued Strong Revenue Growth and Provides Corporate Update

Canada NewsWire May 28, 2025

Innocan secures Mexican patent for topical pain-relief technology

Jonathon Brown May 6, 2025

Innocan Pharma First Granted Patent in Mexico for its Topical Pain Relief

Canada NewsWire May 6, 2025

Innocan Pharma Announces Closing of Private Placement

Canada NewsWire April 15, 2025

Innocan Pharma Broadens Intellectual Property Coverage for its Liposomal CBD Injection Across Asia and Announces Private Placement of Units

Canada NewsWire April 7, 2025

Innocan Pharma Reports Full Year 2024 Results with Revenues more than Doubling to US $29.4 million

Canada NewsWire March 31, 2025

Innocan Pharma Announces Closing of Debenture Unit Offering to its Largest Shareholder, Tamar Innovest Limited

Canada NewsWire March 7, 2025

Innocan Pharma Announces Private Placement Offering of a Debenture Unit to its Largest Shareholder, Tamar Innovest

Canada NewsWire February 27, 2025

Innocan Pharma's Liposomal CBD Injection Shows Breakthrough Pain Relief in Elderly Donkey with Osteoarthritis

Canada NewsWire February 10, 2025

Innocan Pharma's Subsidiary BI Sky Global Completes HRIPT Testing and Surpasses Important Sales Milestone

Canada NewsWire January 29, 2025

FDA's Center for Veterinary Medicine Grants Innocan Pharma a Fee Waiver for 2025

Canada NewsWire January 9, 2025

Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of C$635,444.60

Canada NewsWire December 31, 2024

Innocan Pharma Announces Private Placement of Units

Canada NewsWire December 19, 2024

Innocan Pharma Provides its Annual "State of Research and Development" Update for 2024

Canada NewsWire December 12, 2024

Podcasts